What is HC Wainwright’s Forecast for Quantum-Si Q2 Earnings?

Quantum-Si incorporated (NASDAQ:QSI) – Stock analysts at HC Wainwright lowered their Q2 2025 earnings estimates for Quantum-Si in a research report issued on Thursday, November 21st. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of ($0.19) for the quarter, down from their previous forecast of ($0.17). HC Wainwright has a “Buy” rating and a $5.50 price objective on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.19) EPS, FY2025 earnings at ($0.75) EPS, FY2026 earnings at ($0.69) EPS and FY2027 earnings at ($0.51) EPS.

Separately, Canaccord Genuity Group decreased their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, November 13th.

Quantum-Si Stock Down 10.6 %

NASDAQ:QSI opened at $1.23 on Monday. Quantum-Si has a 52 week low of $0.61 and a 52 week high of $2.43. The stock’s fifty day moving average is $0.88 and its two-hundred day moving average is $1.07. The stock has a market capitalization of $174.82 million, a price-to-earnings ratio of -1.91 and a beta of 2.89.

Hedge Funds Weigh In On Quantum-Si

Several institutional investors have recently modified their holdings of the business. XTX Topco Ltd acquired a new stake in Quantum-Si in the 2nd quarter valued at about $25,000. Public Employees Retirement System of Ohio acquired a new stake in Quantum-Si in the first quarter valued at approximately $27,000. SG Americas Securities LLC purchased a new position in Quantum-Si in the third quarter worth approximately $53,000. Virtu Financial LLC acquired a new position in Quantum-Si during the 1st quarter worth approximately $98,000. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Quantum-Si by 11.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock valued at $118,000 after purchasing an additional 5,945 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.